Literature DB >> 31199160

Differential Proteomics Reveals Discrete Functions of Proteins Interacting with Hypo- versus Hyper-phosphorylated NS5A of the Hepatitis C Virus.

Ting-Chun Pan1, Chieh-Wen Lo1, Weng Man Chong2, Chia-Ni Tsai1, Kuan-Ying Lee1, Pin-Yin Chen1, Jung-Chi Liao2, Ming-Jiun Yu1.   

Abstract

Protein phosphorylation is a reversible post-translational modification that regulates many biological processes in almost all living forms. In the case of the hepatitis C virus (HCV), the nonstructural protein 5A (NS5A) is believed to transit between hypo- and hyper-phosphorylated forms that interact with host proteins to execute different functions; however, little was known about the proteins that bind either form of NS5A. Here, we generated two high-quality antibodies specific to serine 235 nonphosphorylated hypo- vs serine 235 phosphorylated (pS235) hyper-phosphorylated form of NS5A and for the first time segregated these two forms of NS5A plus their interacting proteins for dimethyl-labeling based proteomics. We identified 629 proteins, of which 238 were quantified in three replicates. Bioinformatics showed 46 proteins that preferentially bind hypo-phosphorylated NS5A are involved in antiviral response and another 46 proteins that bind pS235 hyper-phosphorylated NS5A are involved in liver cancer progression. We further identified a DNA-dependent kinase (DNA-PK) that binds hypo-phosphorylated NS5A. Inhibition of DNA-PK with an inhibitor or via gene-specific knockdown significantly reduced S232 phosphorylation and NS5A hyper-phosphorylation. Because S232 phosphorylation initiates sequential S232/S235/S238 phosphorylation leading to NS5A hyper-phosphorylation, we identified a new protein kinase that regulates a delicate balance of NS5A between hypo- and hyper-phosphorylation states, respectively, involved in host antiviral responses and liver cancer progression.

Entities:  

Keywords:  HCV; Hepatocellular carcinoma; NS5A; interactome; kinase; liver cancer; phosphorylation

Mesh:

Substances:

Year:  2019        PMID: 31199160     DOI: 10.1021/acs.jproteome.9b00130

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  6 in total

1.  Sequential Phosphorylation of Hepatitis C Virus NS5A Protein Requires the ATP-Binding Domain of NS3 Helicase.

Authors:  Chun-Chiao Yu; Pei-Chen Lin; Cho-Han Chiang; Shu-Tang Jen; Yen-Ling Lai; Shih-Chin Hsu; Lee-Chiang Lo; Jing-Jer Lin; Nei-Li Chan; Ming-Jiun Yu
Journal:  J Virol       Date:  2022-03-16       Impact factor: 6.549

2.  PACSIN2 Interacts with Nonstructural Protein 5A and Regulates Hepatitis C Virus Assembly.

Authors:  Lap P Nguyen; Si C Tran; Shiro Suetsugu; Yun-Sook Lim; Soon B Hwang
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

3.  Serine 229 Balances the Hepatitis C Virus Nonstructural Protein NS5A between Hypo- and Hyperphosphorylated States.

Authors:  Chia-Ni Tsai; Ting-Chun Pan; Cho-Han Chiang; Chun-Chiao Yu; Shih-Han Su; Ming-Jiun Yu
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

4.  Juncaceae Species as Promising Sources of Phenanthrenes: Antiproliferative Compounds from Juncus maritimus Lam.

Authors:  Norbert Kúsz; Dóra Stefkó; Anita Barta; Annamária Kincses; Nikoletta Szemerédi; Gabriella Spengler; Judit Hohmann; Andrea Vasas
Journal:  Molecules       Date:  2021-02-13       Impact factor: 4.411

5.  Sequential Phosphorylation of the Hepatitis C Virus NS5A Protein Depends on NS3-Mediated Autocleavage between NS3 and NS4A.

Authors:  Cho-Han Chiang; Yen-Ling Lai; Yu-Ning Huang; Chun-Chiao Yu; Christine C Lu; Guann-Yi Yu; Ming-Jiun Yu
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

Review 6.  The current landscape of coronavirus-host protein-protein interactions.

Authors:  Laure Perrin-Cocon; Olivier Diaz; Clémence Jacquemin; Valentine Barthel; Eva Ogire; Christophe Ramière; Patrice André; Vincent Lotteau; Pierre-Olivier Vidalain
Journal:  J Transl Med       Date:  2020-08-18       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.